Canagliflozin, An SGLT2 Inhibitor, Prevents Lung Remodeling in Chronic Left Ventricular Failure
Year: 2024
Type: conference-abstract
Authors: M. Kanuparthy, D.D. Harris, J. Hamze, M. Broadwin, C. Stone, D. Banerjee, F.W. Sellke
Institution: Brown University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4396503770
